JAK2 and myeloproliferative neoplasm: Subsequent identification of further disease initiating mutations, such as those in JAK2 exon 12, MPL exon 10, and CALR exon 9, allows the implementation of molecular diagnostic algorithms that are able to identify a clonal marker of disease in the vast majority of classical MPN patients.